Lucy Therapeutics is a biotechnology company focusing on the development of novel therapies for neurological and mitochondrial diseases. The company aims to address complex disorders by targeting mitochondrial pathways, thereby creating innovative treatments for conditions such as Parkinson's disease and other neurodegenerative illnesses. Leveraging their expertise in mitochondrial biology, Lucy Therapeutics seeks to transform the therapeutic landscape for patients with unmet medical needs.